Company Data
Corcept Therapeutics Incorporated
Ticker
CORT
Current Price
$72.1 -0.06%
Market Cap
$7.6B
Price Target
Refer to Report
Volume
356.5K
52wk Range
$26.87 - $117.33
Overview
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.